Today, Spacewalk VC, together with German venture capital fund Matterwave and Dutch early-stage fund NP-Hard Ventures announce an investment in Roseman Labs.
Founded in 2020, Roseman Labs’ mission is to protect privacy and empower collaboration on sensitive data to tackle global challenges. Its flagship product is the “Virtual Data Lake”, which enables parties to link and analyze data without sharing sensitive source data. This gives parties unprecedented control and privacy guarantees. Privacy rules in Europe are very strict, while the need for data sharing is greater than ever. Roseman Labs’ technology offers a proven solution for this challenge.
An important characteristic of Roseman Labs’ technology is its practical applicability. For example, the company supports Dataspaces for health care organizations. These ground breaking Dataspaces allow participants to securely gather insights and learn more about the quality and effectiveness of care. The technology enables analysis of the patient journey without the need for disclosure of data.
Roseman Labs – already active in healthcare, the social domain, justice and security, financial services and the energy sector – will use the 4 million euro investment to grow the team and expand internationally. Munich-based Matterwave Ventures invests in European early-stage industrial hardware and software companies with technology differentiation. Spacewalk is also a deep-tech VC fund from Munich and part of Motius, a private R&D company that combines the expertise of over 800 experts to create the ‘tech products of the future’. NP-Hard is an early-stage Dutch tech fund founded by three experienced operators.
Roderick Rodenburg, CEO and co-founder of Roseman Labs: “This new investment allows us to take the next step. We have a strong team that combines PhD-level cryptography with software engineering, information security, business and product development experience with whom we have developed a groundbreaking privacy-preserving data science product. This investment provides the scope to grow and to take new steps in marketing our technology abroad.”
“We were impressed by the team’s expertise and experience in both, academic and in commercial contexts. In addition, Roseman Labs platform technology enables unprecedented performance in data collaboration projects, while maintaining absolute privacy”, says Benedikt Kronberger, General Partner at Matterwave Ventures. “We see many different use cases in the industrial sector, from semiconductors, to manufacturing to energy. We believe that connecting data across institutional and geographic boundaries will create tremendous value through transparency and analytics that did not exist before.”
“Roseman is incredibly strong both commercially and technically. The technology itself is already established in a scientific context, but the visionary team at Roseman has managed to make it performantly scalable. Thus, it also works with large amounts of data and can be used industrially,” explains Daniel Weiss, General Partner of Spacewalk and CFO at Motius. “Above all, the user-friendliness of the product convinced us. It was crucial for us that it can be integrated into continuous processes with the customer beyond individual projects. In addition, data protection is mathematically guaranteed. Roseman is therefore perfectly positioned to win new customers in the European and international markets with its product.”
About Spacewalk: Spacewalk is a venture capital fund specializing in deep tech. We focus on early-stage market startups and innovative spinoffs from Motius, a leading German R&D firm. Beyond being investors, we pride ourselves on being technological a sparring partner, and a gateway to an expansive industry network. Our affiliation with Motius offers us unparalleled advantages: direct market insights, access to esteemed clientele, and a pulse on the latest in technology. This positions Spacewalk at the forefront of (pre-)seed investments within the dynamic European deep tech startup scene. With a target fund size of 35 million €, we celebrated our first closing in 2022. Our recent inclusion in the MIT Endowment Fund’s program further cements our connection to avant-garde research.
Contact us for all questions and more information.